%0 Editorial
%T Daily oral ibandronate with adjuvant endocrine therapy in postmenopausal women with estrogen receptor-positive breast cancer: editorial commentary.
%A Coleman R
%J Ann Transl Med
%V 12
%N 4
%D 2024 Aug 1
%M 39118952
%F 3.616
%R 10.21037/atm-2023-3